Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)

NCT00771316 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped feasibility and low enrollment

Conditions

Urinary Tract Infections

Interventions

DRUG: MK0826 (ertapenem)
DRUG: Comparator: meropenem

Sponsor

Merck Sharp & Dohme LLC